P2RX4 and cancer: In patient‐derived tumour organoids from human colorectal cancer, the researcher found that chemotherapy‐induced tumour cell death causes ATP release triggering P2X4 to promote live cancer cell survival in a mammalian target of rapamycin‐dependent manner.45